Sfoglia per Autore
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities
2020 Magnani, C; Gaipa, G; Lussana, F; Belotti, D; Gritti, G; Napolitano, S; Matera, G; Cabiati, B; Buracchi, C; Borleri, G; Fazio, G; Zaninelli, S; Tettamanti, S; Cesana, S; Colombo, V; Quaroni, M; Cazzaniga, G; Rovelli, A; Biagi, E; Galimberti, S; Calabria, A; Benedicenti, F; Montini, E; Ferrari, S; Introna, M; Balduzzi, A; Valsecchi, M; Dastoli, G; Rambaldi, A; Biondi, A
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System
2020 Rotiroti, M; Buracchi, C; Arcangeli, S; Galimberti, S; Valsecchi, M; Perriello, V; Rasko, T; Alberti, G; Magnani, C; Cappuzzello, C; Lundberg, F; Pande, A; Dastoli, G; Introna, M; Serafini, M; Biagi, E; Izsvák, Z; Biondi, A; Tettamanti, S
New findings about the Interplay among Clarithromycin, Immune and Central Nervous Systems
2018 di Giacomo, E; Colmegna, F; Biagi, E; Clerici, M
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia
2018 Fazio, G; Turazzi, N; Cazzaniga, V; Kreuzaler, M; Maglia, O; Magnani, C; Biagi, E; Rolink, A; Biondi, A; Cazzaniga, G
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia
2018 Magnani, C; Mezzanotte, C; Cappuzzello, C; Bardini, M; Tettamanti, S; Fazio, G; Cooper, L; Dastoli, G; Cazzaniga, G; Biondi, A; Biagi, E
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia
2018 Turazzi, N; Fazio, G; Rossi, V; Rolink, A; Cazzaniga, G; Biondi, A; Magnani, C; Biagi, E
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia
2017 Rossig, C; Pule, M; Altvater, B; Saiagh, S; Wright, G; Ghorashian, S; Clifton Hadley, L; Champion, K; Sattar, Z; Popova, B; Hackshaw, A; Smith, P; Roberts, T; Biagi, E; Dreno, B; Rousseau, R; Kailayangiri, S; Ahlmann, M; Hough, R; Kremens, B; Sauer, M; Veys, P; Goulden, N; Cummins, M; Amrolia, P
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia
2017 Arcangeli, S; Rotiroti, M; Bardelli, M; Simonelli, L; Magnani, C; Biondi, A; Biagi, E; Tettamanti, S; Varani, L
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia
2017 Biondi, A; Magnani, C; Tettamanti, S; Gaipa, G; Biagi, E
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies
2017 Rotiroti, M; Arcangeli, S; Casucci, M; Perriello, V; Bondanza, A; Biondi, A; Tettamanti, S; Biagi, E
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation
2017 Introna, M; Lussana, F; Algarotti, A; Gotti, E; Valgardsdottir, R; Micò, C; Grassi, A; Pavoni, C; Ferrari, M; Delaini, F; Todisco, E; Cavattoni, I; Deola, S; Biagi, E; Balduzzi, A; Rovelli, A; Parma, M; Napolitano, S; Sgroi, G; Marrocco, E; Perseghin, P; Belotti, D; Cabiati, B; Gaipa, G; Golay, J; Biondi, A; Rambaldi, A
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform
2016 Magnani, C; Turazzi, N; Benedicenti, F; Calabria, A; Tenderini, E; Tettamanti, S; Giordano Attianese, G; Cooper, L; Aiuti, A; Montini, E; Biondi, A; Biagi, E
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories
2016 Gaipa, G; Introna, M; Golay, J; Nolli, M; Vallanti, G; Parati, E; Giordano, R; Romagnoli, L; Melazzini, M; Biondi, A; Biagi, E
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease
2015 Taddio, A; Tommasini, A; Valencic, E; Biagi, E; Decorti, G; De Iudicibus, S; Cuzzoni, E; Gaipa, G; Badolato, R; Prandini, A; Biondi, A; Ventura, A
Cell-based strategies to manage leukemia relapse: Efficacy and feasibility of immunotherapy approaches
2015 Rambaldi, A; Biagi, E; Bonini, C; Biondi, A; Introna, M
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy
2015 Belotti, D; Gaipa, G; Bassetti, B; Cabiati, B; Spaltro, G; Biagi, E; Parma, M; Biondi, A; Cavallotti, L; Gambini, E; Pompilio, G
Donor-derived CD19-targeted T cells in allogeneic transplants
2015 Magnani, C; Biondi, A; Biagi, E
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients
2014 Introna, M; Lucchini, G; Dander, E; Galimberti, S; Rovelli, A; Balduzzi, A; Longoni, D; Pavan, F; Masciocchi, F; Algarotti, A; Micò, C; Grassi, A; Deola, S; Cavattoni, I; Gaipa, G; Belotti, D; Perseghin, P; Parma, M; Pogliani, E; Golay, J; Pedrini, O; Capelli, C; Cortelazzo, S; D'Amico, G; Biondi, A; Rambaldi, A; Biagi, E
Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain
2014 Pischiutta, F; D'Amico, G; Dander, E; Biondi, A; Biagi, E; Citerio, G; De Simoni, M; Zanier, E
Chimeric Antigen Receptors against CD33/CD123 antigens efficiently target primary Acute Myeloid Leukemia cells in vivo
2014 Pizzitola, I; Anjos Afonso, F; Rouault Pierre, K; Lassailly, F; Tettamanti, S; Spinelli, O; Biondi, A; Biagi, E; Bonnet, D
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile